Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 90%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,649
Total Claims
$592K
Drug Cost
280
Beneficiaries
$2,114
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-43%
Opioid rate vs peers
2.1% vs 3.8% avg
+80%
Cost per patient vs peers
$2,114 vs $1,174 avg
+28%
Brand preference vs peers
11.4% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.1%
Opioid Rate
121
Opioid Claims
$1,996
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 638 claims · $474K
Generic: 4,979 claims · $116K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 61 | $76K |
| Apixaban | 54 | $54K |
| Rifaximin | 17 | $49K |
| Tirzepatide | 37 | $45K |
| Empagliflozin | 35 | $32K |
| Linaclotide | 19 | $15K |
| Naloxegol Oxalate | 16 | $9,330 |
| Budesonide/Formoterol Fumarate | 13 | $8,159 |
| Finerenone | 13 | $8,047 |
| Dexlansoprazole | 14 | $6,068 |
| Umeclidinium Brm/Vilanterol Tr | 11 | $5,513 |
| Famotidine | 150 | $3,410 |
| Montelukast Sodium | 202 | $3,209 |
| Gabapentin | 187 | $3,190 |
| Duloxetine Hcl | 134 | $2,909 |
Prescribing Profile
Patient Profile
69
Avg Age
63%
Female
1.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About